Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4555600016 | Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4555601017 | Aliskiren (as aliskiren fumarate) 300 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only aliskiren and hydrochlorothiazide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Aliskiren (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Aliskiren fumarate (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets